Recommended Pages at aidsmeds.com
AIDSmeds - Top Stories : Truvada Receives PrEP Approval Recommendation - by Tim Horn
aidsmeds.com — “In a series of votes by the U.S. Food and Drug Administration?s Antiviral Drugs Advisory Committee, Truvada (tenofovir plus emtricitabine) has been recommended for approval as the first prescription drug to prevent HIV among those at risk for the infection.” View full resource at aidsmeds.com
Most Recently Shared on May 11, 2012 at 1:06 pm By:
AIDSmeds - Top Stories : Gene-Modified T Cells Persist for a Decade, Without Major Risks, in HIV Studies - by Tim Horn
aidsmeds.com — “Genetically modified T cells--notably CD4 and CD8 cells--administered to people living with HIV participating in one of three clinical trials conducted between 1998 and 2002 are detectable more than a decade later, suggesting that single infusions of cells altered to target or block HIV have the potential for long-term efficacy. According to the paper, published in the May 2 issue of Science Translational Medicine and summarized in a University of Pennsylvania news release, the long-term safety ” View full resource at aidsmeds.com
Most Recently Shared on May 4, 2012 at 12:54 pm By:
Top Stories : Gene-Modified T Cells Persist for a Decade, Without Major Risks, in #HIV Studies http://t.co/CxlMuGLC #AIDS
RT @AIDSmeds Just Updated : A printable drug chart of all approved #HIV medication http://t.co/tuF9HTUO #AIDS
aidsmeds.com — “RT @AIDSmeds Just Updated : A printable drug chart of all approved #HIV medication http://t.co/tuF9HTUO #AIDS” View full resource at aidsmeds.com
Most Recently Shared on May 1, 2012 at 2:25 pm By:
RT @AIDSmeds Just Updated : A printable drug chart of all approved #HIV medication http://t.co/tuF9HTUO #AIDS
AIDSmeds - Top Stories : FDA to Docs: Best to Avoid Victrelis With Norvir-Boosted HIV Protease Inhibitors - by Tim Horn
aidsmeds.com — “Victrelis (boceprevir), Merck?s hepatitis C virus (HCV) protease inhibitor, should not be combined with the following Norvir (ritonavir)-boosted HIV protease inhibitors: Reyataz (atazanavir), Prezista (darunavir) or Kaletra.” View full resource at aidsmeds.com
Most Recently Shared on April 30, 2012 at 1:13 pm By:
Top Stories - FDA to Docs: Best to Avoid Victrelis With Norvir-Boosted #HIV Protease Inhibitors http://t.co/VttAd4rH #hepatitis #HepC #AIDS
AIDSmeds - Top Stories : Report Outlines HIV Cure Research, Important Gaps - by Tim Horn
aidsmeds.com — “Three HIV/AIDS activist groups convened a meeting in March with researchers and representatives of the U.S. Food and Drug Administration (FDA) to describe the current state of cure research and identify barriers to moving such research forward swiftly and smoothly. The proceedings of this meeting, which took place immediately before the 19th Conference on Retroviruses and Opportunistic Infections (CROI) that began on March 5 in Seattle, are now available in a report online.” View full resource at aidsmeds.com
Most Recently Shared on April 25, 2012 at 9:52 pm By:
Top Stories : Report Outlines #HIV #Cure Research, Important Gaps http://t.co/8Oyn9MYq #AIDS @projectinform @tagteam_tweets #atac
AIDSmeds - Top Stories : Hormonal Contraception Not Linked to HIV Risk
aidsmeds.com — “A new analysis of data from a clinical trial conducted by the HIV Prevention Trials Network (HPTN) casts doubt on a study reported last summer suggesting that women using hormonal contraception are at greater risk of acquiring HIV.” View full resource at aidsmeds.com
Most Recently Shared on April 24, 2012 at 1:05 pm By:
Top Stories : Hormonal Contraception Not Linked to #HIV Risk http://t.co/wQrBTJJV #AIDS
AIDSmeds - Top Stories : Engineering CD8 Cells to Kill HIV in Tissues
aidsmeds.com — “Expanding on previous research providing proof-of-concept that human stem cells can be genetically engineered into HIV-fighting cells, researchers at the University of California at Los Angeles (UCLA) have now demonstrated that these cells can actually attack HIV-infected cells in a living organism.” View full resource at aidsmeds.com
Most Recently Shared on April 16, 2012 at 12:53 pm By:
Top Stories : Engineering CD8 Cells to Kill #HIV in Tissues http://t.co/643UH92v #Cure #AIDS
AIDSmeds - Top Stories : Isentress Plus Truvada Is Safe, Potentially Effective as HIV PEP Regimen - by Tim Horn
aidsmeds.com — “Isentress (raltegravir) combined with Truvada (tenofovir plus emtricitabine) was extremely well tolerated as post-exposure prophylaxis (PEP) following high-risk sexual activity in a small study conducted by a team of researchers at Fenway Health in Boston.” View full resource at aidsmeds.com
Most Recently Shared on April 13, 2012 at 1:48 pm By:
Top Stories : Isentress Plus Truvada Is Safe, Potentially Effective as #HIV #PEP Regimen http://t.co/KndrfRAW #AIDS
AIDSmeds - Top Stories : Toward a Cure: The Potential of Therapeutic Vaccines - by Tim Horn
aidsmeds.com — “While gene therapies that render the immune system impervious to HIV and drugs that potentially purge the virus from resting CD4 cells continue to be watched closely by AIDS cure researchers and advocates, therapeutic vaccines may serve an important supporting role in these efforts, according to activist Richard Jefferys, writing in the Spring 2012 TAGline newsletter.” View full resource at aidsmeds.com
Most Recently Shared on April 12, 2012 at 9:40 pm By:
Top Stories - Toward a Cure: The Potential of Therapeutic Vaccines http://t.co/PAthEMB2 #HIV #AIDS
AIDSmeds - Web Exclusives : A Piece of Me - by Tim Horn
aidsmeds.com — “AIDSmeds editor Tim Horn learns more about NDRI, a national HIV tissue and organ donor program, before deciding whether to sign on the bottom line.” View full resource at aidsmeds.com
Most Recently Shared on April 12, 2012 at 7:53 pm By:
Web Exclusive : A Piece of Me - NDRI is only nationwide program collecting tissues and organs from #HIV-positive people http://t.co/MHqnCfWF
AIDSmeds - Top Stories : HIV Contributes to Lung Cancer Risk, but Smoking Matters Most - by Tim Horn
aidsmeds.com — “HIV infection increases the risk of developing lung cancer by about 70 percent, according to a study conducted by U.S. Department of Veterans Affairs researchers and published online ahead of print by the journal AIDS. However, the researchers note, it is smoking among people living with HIV that poses the greatest risk of developing lung cancer.” View full resource at aidsmeds.com
Most Recently Shared on April 12, 2012 at 2:25 pm By:
Top Stories : HIV Contributes to Lung Cancer Risk, but Smoking Matters Most http://t.co/R4tB0ehr #HIV #AIDS
AIDSmeds - Top Stories : HIV Vaccine Study Offers Up Possible Antibody Protection Clues
aidsmeds.com — “Scientists continued to unravel clues as to why a combination of two preventive HIV vaccines, ALVAC HIV and AIDSVAX B/E, may have worked for some but not others in a large scale clinical trial reported in 2009.” View full resource at aidsmeds.com
Most Recently Shared on April 11, 2012 at 4:47 pm By:
Until There's A Cure Health Organization
#HIV Vaccine Study Offers Up Possible Antibody Protection Clues http://t.co/sn2eWy1q @pozmagazine Join the Conversation
AIDSmeds - Top Stories : High Rate of Precancerous Anal Lesions Among HIV-Positive Women - by Tim Horn
aidsmeds.com — “Results from a study conducted in the Bronx, New York, serve as an important reminder to HIV care providers: Comprehensive screening for precancerous anal lesions isn\'t of importance only to HIV-positive men who have sex with men (MSM). According to the Journal of Acquired Immune Deficiency Syndromes report by researchers at Albert Einstein College of Medicine in the Bronx, precancerous lesions are also common among women living with HIV--and testing for them using anal swabs alone may not be s” View full resource at aidsmeds.com
Most Recently Shared on April 5, 2012 at 2:18 pm By:
Top Stories : High Rate of Precancerous Anal Lesions Among HIV-Positive Women http://t.co/0FcG42tI #HIV #AIDS
AIDSmeds - Top Stories : Undetectable Viral Load? Not Necessarily in Semen - by Tim Horn
aidsmeds.com — “Undetectable viral loads in blood is not a guarantee that HIV is also undetectable in semen, according to a new study involving 101 HIV-positive men who have sex with men (MSM) conducted in Boston and published online ahead of print by the journal AIDS.” View full resource at aidsmeds.com
Most Recently Shared on April 3, 2012 at 7:37 pm By:
Top Stories : Undetectable Viral Load? Not Necessarily in Semen http://t.co/Lq85kwv8 #HIV #AIDS
AIDSmeds - Top Stories : Electrocauterization Has Fewer Side Effects, Better Efficacy, Than Topical Treatments for Anal Lesions - by Tim Horn
aidsmeds.com — “When it comes to treating precancerous anal lesions, electrocauterization is both more effective and, somewhat surprisingly, better tolerated than repeated topical applications of either Aldara (imiquimod) or Efudex (fluorouracil), according to data presented Thursday, March 8, at the 19th Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle.” View full resource at aidsmeds.com
Most Recently Shared on March 26, 2012 at 2:15 am By:
Top Stories : Electrocauterization Is Better Than Topical Treatments for Anal Lesions http://t.co/kqO86ZbZ #HIV #AIDS
